Company

Metsera

Biotechnology Research Multiple Therapeutic Targets and Meet the Future Needs of a Rapidly Evolving Weight Loss Treatment Landscape. Founded in 2022 by Population Health Partners and Arch Venture Partners 101 employees AS

Employees: 101
Contacts: 2
Emails: 2
Phones: 1

metsera.com LinkedIn Crunchbase

Metsera Overview

Headquarters: Multiple Therapeutic Targets and Meet the Future Needs of a Rapidly Evolving Weight Loss Treatment Landscape. Founded in 2022 by Population Health Partners and Arch Venture Partners
Website: metsera.com
Industry: Biotechnology Research
Employees: 101
Stock Symbol: AS
Funding: 215.0M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About Metsera

Metsera is a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases. Metsera is advancing a broad portfolio of oral and injectable incretin, non-incretin and combination therapies with potential best-in-class profiles to address multiple therapeutic targets and meet the future needs of a rapidly evolving weight loss treatment landscape. Founded in 2022 by Population Health Partners and ARCH Venture Partners, Metsera has raised $290 million in financing from leading healthcare investors and is based in New York City.

Metsera Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage
Phone contacts: 1; 25.0% coverage

Metsera Org Chart

Sample employees and titles

Name	Title	Location	Contact
Rob Haxton	Biopharma Senior Leader	Macclesfield, England, United Kingdom	Email
Alexander (Sandy) Hurd			View
Shannon Armstrong			View
Mark Stroh	SVP - Head Translational	United States	Email Phone